Plain-English Summary
BMJ Veterans SUD Cohort studied GLP-1 receptor agonists in US veterans with type 2 diabetes. GLP-1 receptor agonist initiation was associated with lower risk of several incident substance use disorder outcomes.
Key Findings
- GLP-1 receptor agonist initiation was associated with lower risk of several incident substance use disorder outcomes.
- Among people with pre-existing SUD, GLP-1RA use was associated with fewer adverse SUD-related outcomes in the study.
Limitations
- Observational study cannot prove causality.
- Veterans with type 2 diabetes may not generalize to broader populations.
- Residual confounding remains possible.
Why It Matters
GLP-1 receptor agonist initiation was associated with lower risk of several incident substance use disorder outcomes.
Viral Vitalism Verdict
Useful evidence, bounded by design: Observational study cannot prove causality.